Skip to Main Content

Paper Details

Immune-Related Adverse Event Likelihood Score Identifies "Pure" IRAEs Strongly Associated With Outcome in a Phase I-II Trial Population.
Oncologist
3
2024
Author NameAffiliation
Chiara CortiIRCCS IEO - Istituto Europeo di Oncologia
Carmen CriscitielloIRCCS IEO - Istituto Europeo di Oncologia
Giuseppe CuriglianoIRCCS IEO - Istituto Europeo di Oncologia
Giuseppe CuriglianoUniversity of Milan
  • 1 - 4

Datasets

Release 1.2